Avanos Medical, Inc.
NYSE:AVNS
24.21 (USD) • At close September 18, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||||
| Nettowinst
| -9.9 | 50.5 | 5.2 | -27.2 | -45.9 | 57.5 | 79.3 | 39.8 | -426.3 | 27.1 | 154.6 | 152.6 | 142.4 |
| Afschrijvingen & Amortisatie
| 46.1 | 47.7 | 38.3 | 42.9 | 36.9 | 33.5 | 59.5 | 65.2 | 65.4 | 85.4 | 69.2 | 57.6 | 51.1 |
| Uitgestelde Inkomstenbelasting
| -6.6 | 0 | -3.4 | 25.9 | -6.5 | 3.7 | -6.2 | -11.5 | 8.2 | -35 | -0.9 | -11.6 | 3.5 |
| Aandelen Gebaseerde Vergoedingen
| 15.8 | 15.9 | 13.2 | 12.1 | 10.5 | 10.5 | 12.6 | 14.8 | 14.1 | 7.9 | 6 | 5.3 | 2.6 |
| Verandering in Werkkapitaal
| -18 | -24.3 | 26 | -67.8 | -59.6 | -143.4 | -4.3 | 91.6 | -17 | 12.8 | -11.9 | 9.6 | -68.3 |
| Vorderingen
| 39 | -24.7 | -10.8 | 45.8 | -0.8 | 67.4 | -15.3 | 8.4 | 9 | 15.1 | -19.5 | 26.4 | -20 |
| Voorraden
| 4.7 | -30.9 | 17.2 | -21.8 | -21.3 | -34.5 | -16.8 | 41 | -20.2 | -2.9 | 14.3 | -15.1 | -13.1 |
| Crediteuren
| -14.4 | 35.4 | -11.9 | -18.9 | -83.6 | -64 | 18.8 | 6.5 | 14.7 | 4.5 | 15.1 | 8 | -7.6 |
| Overig Werkkapitaal
| -47.3 | -4.1 | 31.5 | -72.9 | 46.1 | -112.3 | 9 | 35.7 | -20.5 | -3.9 | -21.8 | -9.7 | -27.6 |
| Overige Niet-Contante Posten
| 5 | 1.1 | 8 | 11.6 | -9.9 | -107.4 | 3.3 | -11.1 | 453.2 | 49.7 | 6.8 | -10.9 | 8.3 |
| Kasstroom uit Operationele Activiteiten
| 32.4 | 90.9 | 87.3 | -2.5 | -74.5 | -145.6 | 144.2 | 188.8 | 97.6 | 147.9 | 223.8 | 202.6 | 139.6 |
| Investeringsactiviteiten: | |||||||||||||
| Investeringen in Materiële Vaste Activa
| -17.8 | -19.3 | -21 | -20.2 | -50.6 | -49.1 | -43.2 | -29.1 | -70.4 | -78.5 | -49 | -40.8 | -39.7 |
| Netto Overnames
| 39.4 | -116.1 | 0 | -4 | -57.5 | 688.6 | 0.1 | -175 | 7.8 | 0 | -2.2 | 0 | -3.7 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.2 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 0 | 0 |
| Overige Investeringsactiviteiten
| 89 | -116.1 | 0 | -4 | -57.5 | 754.3 | 0.1 | 3.2 | 7.8 | 7.8 | -46.5 | 0.5 | 3.9 |
| Kasstroom uit Investeringsactiviteiten
| 21.6 | -135.4 | -21 | -24.2 | -108.1 | 639.5 | -43.1 | -200.9 | -62.6 | -70.7 | -50.9 | -40.3 | -39.5 |
| Financieringsactiviteiten: | |||||||||||||
| Schuldaflossingen
| -64.7 | -296.6 | -70 | -254.8 | -0.2 | -339 | 0 | -72 | -51 | -13.8 | -67.9 | -31.2 | -41.4 |
| Uitgifte van Gewone Aandelen
| 1.3 | 1.7 | 6.2 | 3.4 | 5.3 | 17.1 | 4.7 | 0.4 | 1.4 | 0 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -19.1 | -45.5 | -11.5 | -0.9 | -3.6 | -0.9 | -2.5 | -0.9 | -1 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -680 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| -11.7 | 398.8 | 26.2 | 185.7 | 5.3 | 15.5 | 4.7 | 71.5 | 1.4 | 723 | -112.1 | -102.7 | -73.7 |
| Kasstroom uit Financieringsactiviteiten
| -94.2 | 56.7 | -55.3 | -70 | 1.5 | -324.4 | 2.2 | -1.4 | -50.6 | 29.2 | -180 | -133.9 | -115.1 |
| Overige Informatie: | |||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.2 | -3 | -4 | 2.9 | 1.9 | -4.7 | 2.7 | -2.3 | -3.9 | -1.5 | 3.3 | -0.6 | 0.8 |
| Netto Kasstroomverandering
| -40 | 9.2 | 7 | -93.8 | -179.2 | 164.8 | 106 | -15.8 | -19.5 | 104.9 | -3.8 | 27.8 | -14.2 |
| Kaspositie aan het Einde van de Periode
| 87.7 | 127.7 | 118.5 | 111.5 | 205.3 | 384.5 | 219.7 | 113.7 | 129.5 | 149 | 44.1 | 47.9 | 20.1 |